|
LOC339290 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.807200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.370800E-01 |
| Normal-vs-Stage2 |
8.894000E-01 |
| Normal-vs-Stage3 |
7.953500E-02 |
| Normal-vs-Stage4 |
1.005760E-01 |
| Stage1-vs-Stage2 |
8.248000E-01 |
| Stage1-vs-Stage3 |
1.934430E-02 |
| Stage1-vs-Stage4 |
2.903900E-02 |
| Stage2-vs-Stage3 |
1.869620E-01 |
| Stage2-vs-Stage4 |
1.977560E-01 |
| Stage3-vs-Stage4 |
8.657800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.420000E-01 |
| Normal-vs-AfricanAmerican |
8.110300E-02 |
| Normal-vs-Asian |
9.136000E-01 |
| Caucasian-vs-AfricanAmerican |
1.815790E-02 |
| Caucasian-vs-Asian |
7.016000E-01 |
| AfricanAmerican-vs-Asian |
5.420200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.806300E-02 |
| Normal-vs-Female |
6.841500E-02 |
| Male-vs-Female |
8.03260000000749E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.465900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.150600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.084400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.313800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.407700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.131990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.607600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.481000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.716800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.845000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.386600E-04 |
| Normal-vs-Grade 2 |
1.811360E-01 |
| Normal-vs-Grade 3 |
1.732970E-01 |
| Normal-vs-Grade 4 |
3.221300E-04 |
| Grade 1-vs-Grade 2 |
6.533500E-02 |
| Grade 1-vs-Grade 3 |
2.063300E-03 |
| Grade 1-vs-Grade 4 |
5.61239999999907E-05 |
| Grade 2-vs-Grade 3 |
6.598700E-03 |
| Grade 2-vs-Grade 4 |
1.59749999999459E-05 |
| Grade 3-vs-Grade 4 |
6.255800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.073900E-02 |
| Normal-vs-ccB subtype |
3.86980000000037E-05 |
| ccA subtype-vs-ccB subtype |
4.29649649191788E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.733800E-01 |
| Normal-vs-N1 |
1.242150E-03 |
| N0-vs-N1 |
4.587600E-02 |
|
|
